These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 26350204)

  • 1. Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability.
    Grozeva D; Carss K; Spasic-Boskovic O; Tejada MI; Gecz J; Shaw M; Corbett M; Haan E; Thompson E; Friend K; Hussain Z; Hackett A; Field M; Renieri A; Stevenson R; Schwartz C; Floyd JA; Bentham J; Cosgrove C; Keavney B; Bhattacharya S; ; ; ; Hurles M; Raymond FL
    Hum Mutat; 2015 Dec; 36(12):1197-204. PubMed ID: 26350204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted next generation sequencing in 112 Chinese patients with intellectual disability/developmental delay: novel mutations and candidate gene.
    Yan H; Shi Z; Wu Y; Xiao J; Gu Q; Yang Y; Li M; Gao K; Chen Y; Yang X; Ji H; Cao B; Duan R; Jiang Y; Wang J
    BMC Med Genet; 2019 May; 20(1):80. PubMed ID: 31088393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing.
    Redin C; Gérard B; Lauer J; Herenger Y; Muller J; Quartier A; Masurel-Paulet A; Willems M; Lesca G; El-Chehadeh S; Le Gras S; Vicaire S; Philipps M; Dumas M; Geoffroy V; Feger C; Haumesser N; Alembik Y; Barth M; Bonneau D; Colin E; Dollfus H; Doray B; Delrue MA; Drouin-Garraud V; Flori E; Fradin M; Francannet C; Goldenberg A; Lumbroso S; Mathieu-Dramard M; Martin-Coignard D; Lacombe D; Morin G; Polge A; Sukno S; Thauvin-Robinet C; Thevenon J; Doco-Fenzy M; Genevieve D; Sarda P; Edery P; Isidor B; Jost B; Olivier-Faivre L; Mandel JL; Piton A
    J Med Genet; 2014 Nov; 51(11):724-36. PubMed ID: 25167861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome.
    Kuechler A; Zink AM; Wieland T; Lüdecke HJ; Cremer K; Salviati L; Magini P; Najafi K; Zweier C; Czeschik JC; Aretz S; Endele S; Tamburrino F; Pinato C; Clementi M; Gundlach J; Maylahn C; Mazzanti L; Wohlleber E; Schwarzmayr T; Kariminejad R; Schlessinger A; Wieczorek D; Strom TM; Novarino G; Engels H
    Eur J Hum Genet; 2015 Jun; 23(6):753-60. PubMed ID: 25138099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo loss-of-function mutations in SETD5, encoding a methyltransferase in a 3p25 microdeletion syndrome critical region, cause intellectual disability.
    Grozeva D; Carss K; Spasic-Boskovic O; Parker MJ; Archer H; Firth HV; Park SM; Canham N; Holder SE; Wilson M; Hackett A; Field M; Floyd JA; ; Hurles M; Raymond FL
    Am J Hum Genet; 2014 Apr; 94(4):618-24. PubMed ID: 24680889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of intellectual disability and autism comorbidity through gene panel sequencing.
    Aspromonte MC; Bellini M; Gasparini A; Carraro M; Bettella E; Polli R; Cesca F; Bigoni S; Boni S; Carlet O; Negrin S; Mammi I; Milani D; Peron A; Sartori S; Toldo I; Soli F; Turolla L; Stanzial F; Benedicenti F; Marino-Buslje C; Tosatto SCE; Murgia A; Leonardi E
    Hum Mutat; 2019 Sep; 40(9):1346-1363. PubMed ID: 31209962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High diagnostic yield of syndromic intellectual disability by targeted next-generation sequencing.
    Martínez F; Caro-Llopis A; Roselló M; Oltra S; Mayo S; Monfort S; Orellana C
    J Med Genet; 2017 Feb; 54(2):87-92. PubMed ID: 27620904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-Generation Sequencing in Unexplained Intellectual Disability.
    Sandal S; Verma IC; Mahay SB; Dubey S; Sabharwal RK; Kulshrestha S; Saxena R; Suman P; Kumar P; Puri RD
    Indian J Pediatr; 2024 Jul; 91(7):682-695. PubMed ID: 37804371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation sequencing in nonsyndromic intellectual disability: from a negative molecular karyotype to a possible causative mutation detection.
    Athanasakis E; Licastro D; Faletra F; Fabretto A; Dipresa S; Vozzi D; Morgan A; d'Adamo AP; Pecile V; Biarnés X; Gasparini P
    Am J Med Genet A; 2014 Jan; 164A(1):170-6. PubMed ID: 24307393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing in X-linked intellectual disability.
    Tzschach A; Grasshoff U; Beck-Woedl S; Dufke C; Bauer C; Kehrer M; Evers C; Moog U; Oehl-Jaschkowitz B; Di Donato N; Maiwald R; Jung C; Kuechler A; Schulz S; Meinecke P; Spranger S; Kohlhase J; Seidel J; Reif S; Rieger M; Riess A; Sturm M; Bickmann J; Schroeder C; Dufke A; Riess O; Bauer P
    Eur J Hum Genet; 2015 Nov; 23(11):1513-8. PubMed ID: 25649377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease-causing variants in TCF4 are a frequent cause of intellectual disability: lessons from large-scale sequencing approaches in diagnosis.
    Mary L; Piton A; Schaefer E; Mattioli F; Nourisson E; Feger C; Redin C; Barth M; El Chehadeh S; Colin E; Coubes C; Faivre L; Flori E; Geneviève D; Capri Y; Perrin L; Fabre-Teste J; Timbolschi D; Verloes A; Olaso R; Boland A; Deleuze JF; Mandel JL; Gerard B; Giurgea I
    Eur J Hum Genet; 2018 Jul; 26(7):996-1006. PubMed ID: 29695756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome sequencing identifies major causes of severe intellectual disability.
    Gilissen C; Hehir-Kwa JY; Thung DT; van de Vorst M; van Bon BW; Willemsen MH; Kwint M; Janssen IM; Hoischen A; Schenck A; Leach R; Klein R; Tearle R; Bo T; Pfundt R; Yntema HG; de Vries BB; Kleefstra T; Brunner HG; Vissers LE; Veltman JA
    Nature; 2014 Jul; 511(7509):344-7. PubMed ID: 24896178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Next-Generation Sequencing of Korean Patients With Developmental Delay and/or Intellectual Disability.
    Han JY; Jang JH; Park J; Lee IG
    Front Pediatr; 2018; 6():391. PubMed ID: 30631761
    [No Abstract]   [Full Text] [Related]  

  • 14. De novo and inherited TCF20 pathogenic variants are associated with intellectual disability, dysmorphic features, hypotonia, and neurological impairments with similarities to Smith-Magenis syndrome.
    Vetrini F; McKee S; Rosenfeld JA; Suri M; Lewis AM; Nugent KM; Roeder E; Littlejohn RO; Holder S; Zhu W; Alaimo JT; Graham B; Harris JM; Gibson JB; Pastore M; McBride KL; Komara M; Al-Gazali L; Al Shamsi A; Fanning EA; Wierenga KJ; Scott DA; Ben-Neriah Z; Meiner V; Cassuto H; Elpeleg O; Holder JL; Burrage LC; Seaver LH; Van Maldergem L; Mahida S; Soul JS; Marlatt M; Matyakhina L; Vogt J; Gold JA; Park SM; Varghese V; Lampe AK; Kumar A; Lees M; Holder-Espinasse M; McConnell V; Bernhard B; Blair E; Harrison V; ; Muzny DM; Gibbs RA; Elsea SH; Posey JE; Bi W; Lalani S; Xia F; Yang Y; Eng CM; Lupski JR; Liu P
    Genome Med; 2019 Feb; 11(1):12. PubMed ID: 30819258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of single nucleotide polymorphism-microarray and target gene sequencing in the study of genetic etiology of children with unexplained intellectual disability or developmental delay].
    Gao ZJ; Jiang Q; Cheng DZ; Yan XX; Chen Q; Xu KM
    Zhonghua Er Ke Za Zhi; 2016 Oct; 54(10):740-745. PubMed ID: 27784475
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenic variants in KCNQ2 cause intellectual deficiency without epilepsy: Broadening the phenotypic spectrum of a potassium channelopathy.
    Mary L; Nourisson E; Feger C; Laugel V; Chaigne D; Keren B; Afenjar A; Billette T; Trost D; Cieuta-Walti C; Gerard B; Piton A; Schaefer E
    Am J Med Genet A; 2021 Jun; 185(6):1803-1815. PubMed ID: 33754465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked yield of re-evaluating phenotype and exome/target sequencing data in 33 individuals with intellectual disabilities.
    Xiao B; Qiu W; Ji X; Liu X; Huang Z; Liu H; Fan Y; Xu Y; Liu Y; Yie H; Wei W; Yan H; Gong Z; Shen L; Sun Y
    Am J Med Genet A; 2018 Jan; 176(1):107-115. PubMed ID: 29159939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SETD5 loss-of-function mutation as a likely cause of a familial syndromic intellectual disability with variable phenotypic expression.
    Szczałuba K; Brzezinska M; Kot J; Rydzanicz M; Walczak A; Stawiński P; Werner B; Płoski R
    Am J Med Genet A; 2016 Sep; 170(9):2322-7. PubMed ID: 27375234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo SETD5 loss-of-function variant as a cause for intellectual disability in a 10-year old boy with an aberrant blind ending bronchus.
    Green C; Willoughby J; ; Balasubramanian M
    Am J Med Genet A; 2017 Dec; 173(12):3165-3171. PubMed ID: 28905509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massively parallel sequencing of patients with intellectual disability, congenital anomalies and/or autism spectrum disorders with a targeted gene panel.
    Brett M; McPherson J; Zang ZJ; Lai A; Tan ES; Ng I; Ong LC; Cham B; Tan P; Rozen S; Tan EC
    PLoS One; 2014; 9(4):e93409. PubMed ID: 24690944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.